Pharmicell (005690) — Cash Flow Reinvestment Rate
Pharmicell (005690) has a Cash Flow Reinvestment Rate of 2.17x as of September 2025, reinvesting ₩19.07 Billion (capex ₩622.48 Million plus investments ₩-18.44 Billion) from operating cash flow of ₩8.78 Billion. See Pharmicell free cash flow ratio to measure how efficiently the company converts operating cash flow to free cash.
Reinvestment Rate
Total Reinvested
Operating Cash Flow
Capital Expenditures
Pharmicell Cash Flow Reinvestment Rate (2016–2024)
Historical reinvestment intensity for Pharmicell across 6 annual periods. For the full cash flow conversion analysis, see 005690 cash flow metrics.
Annual Cash Flow Reinvestment Rate for Pharmicell (2016–2024)
Year-by-year capital reinvestment analysis for Pharmicell. See how financially flexible is Pharmicell to measure the company's free cash flow as a share of total liabilities.
| Year | Reinvestment Rate | Total Reinvested (KRW) | Operating CF | Capex | YoY Change |
|---|---|---|---|---|---|
| 2024 | 3.18x | ₩11.14 Billion | ₩3.50 Billion | ₩4.34 Billion | ▲ +215.1% |
| 2023 | 1.01x | ₩11.94 Billion | ₩11.81 Billion | ₩6.02 Billion | ▼ -79.7% |
| 2022 | 4.99x | ₩39.49 Billion | ₩7.91 Billion | ₩18.96 Billion | ▲ +930.4% |
| 2020 | 0.48x | ₩4.35 Billion | ₩8.98 Billion | ₩742.73 Million | ▼ -85.5% |
| 2018 | 3.34x | ₩11.39 Billion | ₩3.40 Billion | ₩4.68 Billion | ▼ -59.7% |
| 2016 | 8.30x | ₩8.21 Billion | ₩988.97 Million | ₩3.85 Billion | — |